Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume II
- PMID: 37781310
- PMCID: PMC10534966
- DOI: 10.3389/fcvm.2023.1282587
Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume II
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
References
-
- Writing Committee M, Ommen SR, Mital S, Burke MA, Day SM, Deswal A, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. (2020) 142:e533–57. 10.1161/CIR.0000000000000938 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources